Oxford Sciences Innovation is a leading science and technology business. They ensure Oxford’s world-leading science moves out of the laboratory and onto the global stage. In partnership with the University of Oxford, OSI creates fundamental technology companies, built on science. They match scientists with experienced entrepreneurs and patient capital to turn idea to impact, discovery to company. They invest in Life Sciences, Deep Tech, Healthtech, AI and Software to create companies taking on challenges like diagnosis and treatment of disease and cancer, hyper resolution microscopy, renewable energy, drones, nuclear fusion and quantum computing. 

Venture Capital

Oxford Sciences Innovation

Principals, Life Sciences

Ed Bussey

William Goodlad

Katherine Ward

Joel Schoppig

Matthew Myers

Selina Greuel

Nathan Notwell

Claire Larocca

Tony Besse

Sanne De Jongh

Athene Blakeman

Lilly Bussmann

Sarah Shackelton

Katya Smirnyagina

Sam Harman

Nick Dixon-Clegg

James Wong

Claire Brown

Liliane Chamas

Charo Bajo

Gaelle Akkouche

Lisa Bedwell

Pete Wilder

Polly Elvin

Kate O’Brien

Jim Wilkinson

Jack Edmondson

The leadership team at Oxford Sciences Innovation has a long history of experience in a variety of industries. The team has a wealth of experience in business and law, and their education histories reflect this. The team has a strong understanding of the legal landscape and the businesses they work with, which allows them to provide valuable insights and guidance to the company.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Oxford Sciences Innovation

Board of Directors

CEO and Executive Team